Hedge Fund

DME Capital Management, LP

New York, NY SEC Registered Investment Advisor Institutional CIK: 0001489933
13F Score ?
3Y · Top 10 · Mgr Wt
13F Score ?
7Y · Top 10 · Mgr Wt
S&P 500 ?
80
Benchmark
$3.19B
AUM
+0.00%
2026 Q1
-3.93%
1-Year Return
+57.12%
Top 10 Concentration
+12.80%
Turnover
+11.98%
AUM Change
Since 2024
First Filing
45
# of Holdings

Fund Overview

13F Filed: 2026-05-15

As of 2026 Q1, Dme Capital Management, Lp manages $3.19B in reported 13F assets , holds 45 positions with +57.12% top-10 concentration , and delivered a 1-year return of -3.93% on its disclosed equity portfolio. Filing 13F reports since 2024.

About

Investment Strategy

Analytics Summary

Risk Profile

Key Personnel

David M. Einhorn — Founder, President and Portfolio Manager
Official 13F Filings — SEC EDGAR Key personnel and Fund Overview may contain mistakes

Activity Summary — 2026 Q1

Q1 2026 13F Filed: May 15, 2026

Top Buys

% $
Stock % Impact
+3.51%
+2.27%
+1.74%
+1.66%
+1.48%
+1.41%

Top Sells

% $
Stock % Impact
Sold All 😨 Was: 3.56% -3.18%
-1.39%
Sold All 😨 Was: 1.55% -1.38%
-1.14%
Sold All 😨 Was: 1.23% -1.10%
-0.92%

Top Holdings

2026 Q1
Stock %
19.12%
6.94%
6.10%
5.33%
3.65%
3.51%
View All Holdings

Activity Summary

Latest
Market Value $3.19B
AUM Change +11.98%
New Positions 11
Increased Positions 15
Closed Positions 7
Top 10 Concentration +57.12%
Portfolio Turnover +12.80%
Alt Turnover +18.15%

Sector Allocation Trends

Quarterly History
Free View: Last 10 Quarters. Subscribe to see full history

Holdings Analysis

Size: % of Portfolio Color: Last Full-Quarter Return No data
Free: 10 quarters

Positions Dynamics

Visualizing Top 20 holdings weight history over the last 10 quarters.

Portfolio Analytics — Latest

DME Capital Management, LP risk dashboard covering volatility, beta, value-at-risk, drawdowns, concentration, factor tilts, benchmark comparison, and stress testing for the latest disclosed portfolio.

Risk access
Building institutional risk profile...
Guru Intelligence Hub Pro
Real-time Analytics
High-Conviction Alpha
AAPL 92.4
NVDA 88.1
MSFT 74.3
Strategy Guardian
Style Drift 0.12
Sector Rotation 0.38

Tracking institutional benchmark deviation

Scenario Lab
2008 GFC -32.4%
Covid-19 -18.1%
2022 Bear -24.7%
Unlock the full Guru Intelligence Hub
Real conviction scores for every holding  ·  Strategy Guardian alerts  ·  Live Scenario Lab stress tests
Upgrade to Pro

Best Strategy vs. Benchmarks

AI Backtest: Auto-Optimizing...
Loading AI Backtest...
Don't be Fooled by Randomness
Access Alpha, Capture Ratios, and Batting Average calibrated for this specific strategy.
UPGRADE NOW
Nassim Taleb — author of Fooled by Randomness
Returns
--
Latest Quarter
--
1-Year Return
--
Ann. Return
Risk
--
Std Deviation
--
Max Drawdown
--
Beta vs SPY
Quality
--
Sharpe
--
Sortino
--
Win Rate
--
Payoff Ratio
Edge Metrics Last 10 quarters only
--
Alpha annualized
--
Up Capture
--
Down Capture

Strategy Backtester: DME Capital Management, LP

Replicate top holdings performance • Compare vs benchmarks • Optimize N

Find the best N! Test multiple portfolio sizes at once to discover the optimal configuration.

Risk insights! Identify periods when the fund lagged the benchmark – critical for timing entries.

⏱ Run Backtest

Liquid Glass Edition

0
Backtests Run
+127%
Avg. Return

👆 Click the button to launch tickers!

Don't Be Fooled by Randomness
Proven alpha spans cycles, not just 24 months. Unlock full history since 1999.
PRO ACCESS
Free Demo
Try the Backtester on Real Funds
Run full-history backtests on a curated 2-3 funds. See signal quality, drawdowns, and cycle behavior before you decide.
Underperformance Analysis — Top 10 Holdings vs SPY

Backtesting DME Capital Management, LP's top 10 holdings against SPY identified 7 underperformance periods. Worst drawdown: 2024-10 – 2024-12 (-19.2% vs SPY, 3 quarters). Currently underperforming.

Avg. lag: -10.0% vs SPY Avg. duration: 2.3 quarters
Backtest Snapshot — Top 10 Holdings (Mn-Weighted)

The ticker-level breakdown shows how each of DME Capital Management, LP's top holdings contributed to portfolio returns quarter by quarter. Strongest recent contributors inside the last 5 years of the quarterly Top 10 backtest window: GRBK (2024 Q1 – 2025 Q4, +6.8 pts), BHF (2024 Q1 – 2025 Q4, +3.2 pts), CNC (2024 Q4 – 2025 Q4, +2.6 pts), DHT (2025 Q1 – 2025 Q3, +1.9 pts), TEVA (2025 Q3 – 2025 Q4, +1.5 pts) .

Strategy ann.: 4.6% SPY ann.: 22.1% Period: 2024–2026
Best Recent Contributors — Last 5Y
2 of 5 recent top contributors lagged SPY, which means even some of this fund's best return drivers still failed to beat a simple index over the same window.
2024 Q1 – 2025 Q4 • 8Q in Top 10 Lagged SPY
GRBK
+6%
SPY
+43%
Contrib
+6.8%
2024 Q1 – 2025 Q4 • 8Q in Top 10 Lagged SPY
BHF
+37%
SPY
+43%
Contrib
+3.2%
2024 Q4 – 2025 Q4 • 2Q in Top 10 Beat SPY
CNC
+49%
SPY
+5%
Contrib
+2.6%
2025 Q1 – 2025 Q3 • 3Q in Top 10 Beat SPY
DHT
+42%
SPY
+17%
Contrib
+1.9%
2025 Q3 – 2025 Q4 • 2Q in Top 10 Beat SPY
TEVA
+38%
SPY
+11%
Contrib
+1.5%
Stock return (green = beat SPY)   Stock return (red = lagged SPY)   SPY same period   Cumulative contribution during the last 5 years of the quarterly Mn-weighted Top 10 strategy

Frequently Asked Questions

What does Dme Capital Management, Lp invest in?
DME Capital Management employs David Einhorn's signature value-oriented investment approach, characterized by deep fundamental research, concentrated positioning, and willingness to take contrarian stances against market consensus. The strategy emphasizes identifying significant mispricings between market valuations and intrinsic business value, with holding periods extending as long as necessary for value recognition to occur. Historical **13F Portfolio Composition** analysis reveals concentrated equity positions reflecting high-conviction ideas. Einhorn's investment style incorporates both long positions in undervalued securities and notable short-selling activity—though short positions do not appear in 13F filings, the long portfolio often reflects paired trade logic or hedged positioning. The firm has historically maintained exposure across financials, technology, natural resources, and special situations where Einhorn identifies catalyst-driven value realization opportunities. The **Top 10 Holdings Concentration** observable through quarterly filings typically demonstrates significant position sizing in best ideas, consistent with Einhorn's stated philosophy that diversification beyond conviction holdings dilutes returns. This concentrated approach amplifies both upside potential and downside risk, reflecting the investor's confidence in fundamental research quality. Einhorn's willingness to engage in activist situations—publicly advocating for corporate changes to unlock value—adds an additional dimension to position management.
What is Dme Capital Management, Lp's AUM?
Dme Capital Management, Lp reported $3.19B in 13F assets as of 2026 Q1. Note: 13F AUM reflects only long equity positions reported to the SEC and may differ from total assets under management.
How concentrated is Dme Capital Management, Lp's portfolio?
Dme Capital Management, Lp holds 45 disclosed positions. The top 10 holdings represent +57.12% of the reported portfolio, indicating a highly concentrated investment approach.
How to track Dme Capital Management, Lp 13F filings?
Track Dme Capital Management, Lp's quarterly filings on SEC EDGAR or on this page — data is updated within days of each filing deadline. Subscribe to 13Foresight for position-change alerts.
Who manages Dme Capital Management, Lp?
Dme Capital Management, Lp is managed by David M. Einhorn (Founder, President and Portfolio Manager).

Disclaimer: 13Foresight is not a registered investment adviser, broker-dealer, or financial planner. All information on this site is provided solely for informational and educational purposes and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Portfolio backtests shown on this page are hypothetical and simulated — they do not represent actual trading results and were constructed with the benefit of hindsight. Actual results would differ materially. 13F filings disclose only long equity positions valued above $10,000, submitted up to 45 days after quarter-end; they do not capture short positions, options, bonds, cash, private investments, or non-U.S. securities. A fund's backtest performance may not reflect its actual returns, as managers frequently generate alpha through strategies not visible in 13F data. Past performance is not indicative of future results. All data sourced from public SEC EDGAR filings. Use at your own risk. Full Terms of Use.

Full history →